华东医药：控股子公司获得药物临床试验批准通知书

Group 1 - Company Zhejiang Daor Bio-Tech Co., Ltd., a subsidiary of Huadong Medicine, has received approval from the U.S. FDA for its clinical trial application for the drug DR10624 injection [1] - The approved clinical trial is aimed at treating Severe Hypertriglyceridemia (SHTG) [1]